Back

IABP-SHOCK II risk score validation for cardiogenic shock after myocardial infarction in a cohort treated with pharmaco-invasive therapy

1 September 2019 (15:45 - 16:35)
Organised by:
Congress Presentation Part of: Assessment and management of patients with myocardial infraction and shock Shock ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mr Pedro Ivo De Marqui Moraes

Federal University of Sao Paulo (UNIFESP), Sao Paulo (Brazil)

4 More presentations in this session

Presentation thumbnail
Cardiogenic shock without severe left ventricular dysfunction after st-elevation acute myocardial infarction: population characterization and impact in prognosis
Doctor B. Picarra (Evora, PT)
Abstract Slides
Presentation thumbnail
The predictor of mortality and neurological outcome in out-of-hospital cardiac arrest patients with non-ST-segment elevation
Doctor J. Matsuda (Saitama, JP)
Abstract Slides
Presentation thumbnail
CTEPH patients long term follow-up: results from a single center
Miss S. Mladoniczky (Budapest, HU)
Abstract Slides
Presentation thumbnail
Incidence and prognostic impact of sepsis in patients with acute myocardial infarction complicated by cardiogenic shock - Results of the CULPRIT-SHOCK study and registry
Professor U. Zeymer (Ludwigshafen, DE)
Abstract Slides

Access the full session

Session thumbnail
Assessment and management of patients with myocardial infraction and shock

The Event

Event poster

ESC Congress 2019

1 September 2019 15:45 CET
You may be interested in
thumbnail
Congress Presentation
Comparison of risk prediction models in infarct-related cardiogenic shock
27 August 2021
thumbnail
Congress Presentation
Outcomes in patients with intermediate-high risk pulmonary embolism submitted to catheter-directed therapy presenting with normotensive-shock
20 March 2026
thumbnail
Congress Presentation
IABP in acuteHF
21 March 2026
thumbnail
Congress Presentation
Pre-treatment with P2Y12 inhibitors in acute myocardial infarction with cardiogenic shock
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources